Back to search

United States· US:24689-792_2d125642-5083-4147-e063-6394a90a329c

Terazosin Hydrochloride

A terazosin product containing terazosin hydrochloride, registered in United States by Apnar Pharma LP. The same ATC class is registered in 12 of our 19 countries.

ATC G04CA03Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedTerazosin HydrochlorideATCG04CA03REGISTER NO.US:24689-792_2d125642…PACKS LISTED3CHECKEDSeptember 12, 2026

Where it is registered

Terazosin is registered in 12 of 19 countries.

Countries holding a registration under ATC G04CA03 (terazosin), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose

Terazosin · ATC G04CA03

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of terazosin costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.19 in United States to $0.93 in Switzerland — a ×5.0 gap.

  • United States: $0.19 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Terazosin · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.93
  • IT Italy$0.31
  • US United States$0.19 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
Terazosin Hydrochloride
Manufacturer
Apnar Pharma LP
Country
United States (US)
ATC code
G04CA03
ATC class
Terazosin
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 3

  • ndc11
    2468979201
    100 CAPSULE in 1 BOTTLE (24689-792-01)
  • ndc11
    2468979203
    90 CAPSULE in 1 BOTTLE (24689-792-03)
  • ndc11
    2468979210
    1000 CAPSULE in 1 BOTTLE (24689-792-10)

Regulatory notes

UNII (FDA substance ID)
D32S14F082
TERAZOSIN HYDROCHLORIDE
RxCUI 235224
Orange Book
A074823
ABABABAB
DailyMed SPL labels
1 version tracked

Interactions

186 interactions on record for terazosin.

Graded by severity as the source publishes them — 72 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Terazosin · interactions on record

186 records

  • 72 moderate
  • 1 minor
  • 112 info

Most severe, free to view

  • ThiethylperazinA04AB03moderate
  • DiphenhydraminA04AB05moderate
  • DronabinolA04AD10moderate
  • NabiloneA04AD11moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Terazosin in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All terazosin products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Uroflo, Vicard
  • Belgium · Hytrin, Terazosab
  • Czechia · Kornam
  • Germany · Heitrin, Tera Tad
  • Denmark · Sinalfa
  • Spain · Alfaprost, Mayul
  • France · Dysalfa, Hytrine
  • United Kingdom (Northern Ireland) · Hytrin, Terazosin
  • Greece · Hytrin
  • Hungary · Setegis
  • Ireland · Hytrin
  • Italy · Itrin, Prostatil
  • Luxembourg · Hytrin, Terazosab
  • Netherlands · Hytrin, Terazosine Accord
  • Norway · Sinalfa
  • Poland · Hytrin, Kornam
  • Portugal · Hytrin
  • Sweden · Sinalfa
  • Slovenia · Kornam
  • Slovakia · Kornam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/abe225ff-eddc-4bb8-ae9b-9ecf6ec0baf5
GET /v1/drugs/abe225ff-eddc-4bb8-ae9b-9ecf6ec0baf5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "D32S14F082",
    "rxcui": "235224",
    "inchikey": "NZMOFYDMGFQZLS-UHFFFAOYSA-N",
    "display_name": "TERAZOSIN HYDROCHLORIDE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 5
  },
  "spl_meta": {
    "b77a4a38-edb1-412e-97af-d49e862b32c1": {
      "match": "brand_token",
      "title": "TERAZOSIN CAPSULE [BRYANT RANCH PREPACK]",
      "spl_version": "1",
      "published_date": "2026-05-25"
    }
  },
  "productid": "24689-792_2d125642-5083-4147-e063-6394a90a329c",
  "productndc": "24689-792",
  "dosage_form": "CAPSULE",
  "orange_book": {
    "appl_no": "074823",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 1MG BASE",
        "product_no": "001",
        "approval_date": "Mar 30, 1998"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 2MG BASE",
        "product_no": "002",
        "approval_date": "Mar 30, 1998"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 5MG BASE",
        "product_no": "003",
        "approval_date": "Mar 30, 1998"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AB",
        "strength": "EQ 10MG BASE",
        "product_no": "004",
        "approval_date": "Mar 30, 1998"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "TERAZOSIN HYDROCHLORIDE",
  "proprietary_name": "Terazosin Hydrochloride",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA074823",
  "marketing_category": "ANDA",
  "nonproprietary_name": "Terazosin Hydrochloride",
  "start_marketing_date": "20200630",
  "active_numerator_strength": "1"
}

See everything about terazosin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.